Apr
12
2023
On demand
Large-scale production of hiPSCs in automated bioreactors to produce wholly-cellular bioinks for tissue engineering
Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
Culturing human induced pluripotent stem cells (hiPSCs) suitable for bioprinting applications requires billions of cells, which can differentiate into the desired cell types for tissue engineering. It is challenging to select optimal, reproducible, and scalable process conditions, and culture media, for generating high-yield, functional hiPSCs.
In this webinar, Mark Skylar-Scott, Ph.D., Assistant Professor of Bioengineering at Stanford, and Debbie L. Ho, Basic Life Science Researcher at Stanford, showcase an optimized culture-to-3D bioprinting pipeline for billion cell-scale tissue engineering.
Watch now to:
- Learn more about how bioprinting can increase the availability of organs
- Explore alternatives to using 2-D flask cultures to generate required cell quantities
- Understand how a DoE approach can create efficiencies in your culture process
- Learn strategies to maintain hiPSC pluripotency at various bioreactor scales
SPEAKERS
You might also like
Mastering AAV production: best practices For small- to large-scale manufacturing success and reduced development time
Emily Jackson-Holmes
21 May
Watch
Industry highlights: switching from manual to automated hematopoietic stem cell (HSC) gene engineering
A Marques Gomes, A Rubio Gomes, U Bissels et al.
6 November
Watch
Commercial-scale manufacture of lentivirus for ex vivo and in vivo therapies
Rachel Legmann, Michelle Yen Tran
28 March
Watch
Creating a closed-process, semi-automated workflow for human MSC expansion, harvest, and final fill
Julien Muzard, Donnie Beers
30 May
Watch
Analytical strategies for sterility and mycoplasma testing in biotherapies: from early development to production scale-up
Sharon Rouw, Michael Brewer
3 July
Watch